JOUD HAJJAR to Aged, 80 and over
This is a "connection" page, showing publications JOUD HAJJAR has written about Aged, 80 and over.
Connection Strength
0.186
-
Fatigue and the wear-off effect in adult patients with common variable immunodeficiency. Clin Exp Immunol. 2018 12; 194(3):327-338.
Score: 0.070
-
Increased Incidence of Fatigue in Patients with Primary Immunodeficiency Disorders: Prevalence and Associations Within the US Immunodeficiency Network Registry. J Clin Immunol. 2017 Feb; 37(2):153-165.
Score: 0.062
-
Decrease in tumor content assessed in biopsies is associated with improved treatment outcome response to pembrolizumab in patients with rare tumors. J Immunother Cancer. 2020 04; 8(1).
Score: 0.019
-
Phase 2 study of pembrolizumab in patients with advanced rare cancers. J Immunother Cancer. 2020 03; 8(1).
Score: 0.019
-
Incidence of immune-related adverse events and its association with treatment outcomes: the MD Anderson Cancer Center experience. Invest New Drugs. 2018 08; 36(4):638-646.
Score: 0.016